Gastroenterology Research and Practice / 2017 / Article / Tab 3 / Clinical Study
Clinical Application of CT-Guided Percutaneous Microwave Ablation for the Treatment of Lung Metastasis from Colorectal Cancer Table 3 Literatures related to the ablation of lung metastases from colorectal cancer in recent years.
Author institution Recruitment period Characteristics of patients Patient with LM from CRC Key outcomen Wolf et al. 2008 [24 ] 2003–2006 ; 28 men, 22, women; mean age 70 years9 Residual disease and recurrent disease of the ablation was 22% and 26%, respectively. Vogl et al. 2001 [30 ] 2007–2010 ; 30 men, 50 women; mean age 59.7 years40 (58 lesions) New metastases developed in patients with colorectal cancer 7.5%. Lu et al. 2012 [25 ] 2005–2008 ; 45 men, 24 women; mean age 65 years7 Local progress of masses appeared 21.74%. Wolf et al. 2012 [31 ] 2009-2010 ; 6 men, 4 women; mean age 71 years1 The risk of local disease progression was decreased. Raspanti et al. 2014 [32 ] 2009–2012 , 36 nodules21 (36 lesions) Residual disease was observed about 2.8%. Vogl et al. 2016 [21 ] 2000–2014 ; 71 men, 38 women; mean age 68.6 years47 (103 lesions) Local progress of masses appeared 12%.
LM: lung metastases; CRC: colorectal cancer. n The histopathologic type of the metastasis was not a statistically significant factor when correlating with the ablation result [25 , 30 ].